These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31114506)

  • 1. Neuronal Redox-Imbalance in Rett Syndrome Affects Mitochondria as Well as Cytosol, and Is Accompanied by Intensified Mitochondrial O
    Can K; Menzfeld C; Rinne L; Rehling P; Kügler S; Golubiani G; Dudek J; Müller M
    Front Physiol; 2019; 10():479. PubMed ID: 31114506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative burden and mitochondrial dysfunction in a mouse model of Rett syndrome.
    Grosser E; Hirt U; Janc OA; Menzfeld C; Fischer M; Kempkes B; Vogelgesang S; Manzke TU; Opitz L; Salinas-Riester G; Müller M
    Neurobiol Dis; 2012 Oct; 48(1):102-14. PubMed ID: 22750529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Mitochondrial Mass and Cytosolic Redox Imbalance in Hippocampal Astrocytes of a Mouse Model of Rett Syndrome: Subcellular Changes Revealed by Ratiometric Imaging of JC-1 and roGFP1 Fluorescence.
    Bebensee DF; Can K; Müller M
    Oxid Med Cell Longev; 2017; 2017():3064016. PubMed ID: 28894505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overshooting Subcellular Redox-Responses in Rett-Mouse Hippocampus during Neurotransmitter Stimulation.
    Festerling K; Can K; Kügler S; Müller M
    Cells; 2020 Nov; 9(12):. PubMed ID: 33255426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The free radical scavenger Trolox dampens neuronal hyperexcitability, reinstates synaptic plasticity, and improves hypoxia tolerance in a mouse model of Rett syndrome.
    Janc OA; Müller M
    Front Cell Neurosci; 2014; 8():56. PubMed ID: 24605086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial free radical overproduction due to respiratory chain impairment in the brain of a mouse model of Rett syndrome: protective effect of CNF1.
    De Filippis B; Valenti D; de Bari L; De Rasmo D; Musto M; Fabbri A; Ricceri L; Fiorentini C; Laviola G; Vacca RA
    Free Radic Biol Med; 2015 Jun; 83():167-77. PubMed ID: 25708779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired hippocampal Ca2+ homeostasis and concomitant K+ channel dysfunction in a mouse model of Rett syndrome during anoxia.
    Kron M; Müller M
    Neuroscience; 2010 Nov; 171(1):300-15. PubMed ID: 20732392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Feeding of an Antioxidant Cocktail as a Therapeutic Strategy in a Mouse Model of Rett Syndrome: Merits and Limitations of Long-Term Treatment.
    Baroncelli L; Auel S; Rinne L; Schuster AK; Brand V; Kempkes B; Dietrich K; Müller M
    Antioxidants (Basel); 2022 Jul; 11(7):. PubMed ID: 35883897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excitation/inhibition imbalance and impaired synaptic inhibition in hippocampal area CA3 of Mecp2 knockout mice.
    Calfa G; Li W; Rutherford JM; Pozzo-Miller L
    Hippocampus; 2015 Feb; 25(2):159-68. PubMed ID: 25209930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations.
    Chapleau CA; Calfa GD; Lane MC; Albertson AJ; Larimore JL; Kudo S; Armstrong DL; Percy AK; Pozzo-Miller L
    Neurobiol Dis; 2009 Aug; 35(2):219-33. PubMed ID: 19442733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
    Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
    Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Proteome Changes in Rett Syndrome.
    Golubiani G; van Agen L; Tsverava L; Solomonia R; Müller M
    Biology (Basel); 2023 Jul; 12(7):. PubMed ID: 37508386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docosahexaenoic acid increased MeCP2 mediated mitochondrial respiratory complexes II and III enzyme activities in cortical astrocytes.
    Dave A; Pillai PP
    J Biochem Mol Toxicol; 2022 Apr; 36(4):e23002. PubMed ID: 35174922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial Dysfunction in the Pathogenesis of Rett Syndrome: Implications for Mitochondria-Targeted Therapies.
    Shulyakova N; Andreazza AC; Mills LR; Eubanks JH
    Front Cell Neurosci; 2017; 11():58. PubMed ID: 28352216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disturbed redox homeostasis and oxidative stress: Potential players in the developmental regression in Rett syndrome.
    Müller M
    Neurosci Biobehav Rev; 2019 Mar; 98():154-163. PubMed ID: 30639673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome.
    De Felice C; Della Ragione F; Signorini C; Leoncini S; Pecorelli A; Ciccoli L; Scalabrì F; Marracino F; Madonna M; Belmonte G; Ricceri L; De Filippis B; Laviola G; Valacchi G; Durand T; Galano JM; Oger C; Guy A; Bultel-Poncé V; Guy J; Filosa S; Hayek J; D'Esposito M
    Neurobiol Dis; 2014 Aug; 68(100):66-77. PubMed ID: 24769161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced seizure threshold and altered network oscillatory properties in a mouse model of Rett syndrome.
    McLeod F; Ganley R; Williams L; Selfridge J; Bird A; Cobb SR
    Neuroscience; 2013 Feb; 231():195-205. PubMed ID: 23238573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defects in brainstem neurons associated with breathing and motor function in the Mecp2R168X/Y mouse model of Rett syndrome.
    Johnson CM; Zhong W; Cui N; Wu Y; Xing H; Zhang S; Jiang C
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C895-C909. PubMed ID: 27653984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic, semi-quantitative imaging of intracellular ROS levels and redox status in rat hippocampal neurons.
    Funke F; Gerich FJ; Müller M
    Neuroimage; 2011 Feb; 54(4):2590-602. PubMed ID: 21081169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of adenosinergic system in Rett syndrome: Novel therapeutic target to boost BDNF signalling.
    Miranda-Lourenço C; Duarte ST; Palminha C; Gaspar C; Rodrigues TM; Magalhães-Cardoso T; Rei N; Colino-Oliveira M; Gomes R; Ferreira S; Rosa J; Xapelli S; Armstrong J; García-Cazorla À; Correia-de-Sá P; Sebastião AM; Diógenes MJ
    Neurobiol Dis; 2020 Nov; 145():105043. PubMed ID: 32798727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.